BCWORLD PHARM. Co. Ltd (200780) — Capital Reinvestment Ratio
Latest as of September 2025:
1.14x
BCWORLD PHARM. Co. Ltd (200780) has a Capital Reinvestment Ratio of 1.14x as of September 2025, meaning it reinvests 1% of its operating cash flow (₩1.43 Billion) in capital expenditures (₩1.63 Billion). See BCWORLD PHARM. Co. Ltd (200780) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.14x
Capex / Operating Cash Flow
Operating Cash Flow
₩1.43 Billion
KRW
Capital Expenditures
₩1.63 Billion
KRW
Data as of
Sep 2025
Most recent filing
BCWORLD PHARM. Co. Ltd Capital Reinvestment Ratio (2015–2024)
This chart tracks BCWORLD PHARM. Co. Ltd's Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for BCWORLD PHARM. Co. Ltd (2015–2024)
Year-by-year Capital Reinvestment Ratio for BCWORLD PHARM. Co. Ltd from 2015 to 2024. For live market cap and broader valuation context, see 200780 market cap.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.60x | ₩4.04 Billion | ₩2.41 Billion | ▲ +140.5% |
| 2023 | 0.25x | ₩10.94 Billion | ₩2.71 Billion | ▼ -72.6% |
| 2022 | 0.90x | ₩6.88 Billion | ₩6.22 Billion | ▼ -48.7% |
| 2019 | 1.76x | ₩12.11 Billion | ₩21.32 Billion | ▼ -68.6% |
| 2018 | 5.60x | ₩5.34 Billion | ₩29.92 Billion | ▲ +167.0% |
| 2017 | 2.10x | ₩7.90 Billion | ₩16.58 Billion | ▼ -95.9% |
| 2016 | 51.55x | ₩243.66 Million | ₩12.56 Billion | ▲ +1692.4% |
| 2015 | 2.88x | ₩8.78 Billion | ₩25.26 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow